AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2019
Jun 13, 2019
33153_dirs_2019-06-13_dd46bb95-8936-4c84-a5ad-ec3174039968.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO (MLAB)
CIK: 0000724004
Period of Report: 2019-06-10
Reporting Person: Archbold Brian David (SVP of Continuous Improvement)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Restricted Stock Award | 310 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $0 | Common Stock (350) | Direct | ||
| Non Qualified Stock Option | $129.1 | 2024-01-08 | Common Stock (580) | Direct | |
| Non Qualified Stock Option | $142.4 | 2024-04-02 | Common Stock (1050) | Direct | |
| Non Qualified Stock Options | $203.54 | 2025-06-10 | Common Stock (2129) | Direct |
Footnotes
F1: RSUs vest 1/5 on June 15, 2019 and each of next four anniversary dates
F2: Not Applicable
F3: RSA vests 1/5 on January 6, 2020 and each of the next three anniversary dates
F4: 1/4 exercisable on January 8, 2020 and each of the next three anniversary dates
F5: 1/5 exercisable on April 2,2019 and each of the next four anniversary dates
F6: 1/4 exercisable on June 10, 2020 and each of the next three anniversary dates
More from MESA LABORATORIES INC /CO/
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6